Latest News

ModernVivo joins Debiopharm Innovation Fund Portfolio

Octozi joins Debiopharm Innovation Fund Portfolio

Altislabs’ AI tool could help drugmakers cut risk in late-stage cancer trials

Raidium joins Debiopharm Innovation Fund Portfolio

The future of secure Data Collaboration in Healthcare and AI

Genialis advances biomarker discovery to reduce risk in cancer drug development targeting DNA damage response pathways

Debiopharm Innovation Fund welcomes Hope AI to their portfolio

Tempus announces a collaboration with Genialis to develop RNA-based biomarker algorithms

Debiopharm Innovation Fund: Leading European Digital Health investor with award-winning portfolio companies